Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H B Jones

Showing results (101-110 of 111) with videos related to

Pageof 12
Sort By:
Diabetes, Obesity & Metabolism|October 1, 2010
The novel sodium glucose transporter 2 inhibitor dapagliflozin sustains pancreatic function and preserves islet morphology in obese, diabetic ratsF R Macdonald, J E Peel, H B Jones, et al.
Surgical Endoscopy|February 15, 2001
Laparoscopic inguinal hernia repair: lessons learned after 1224 consecutive casesB Ramshaw, F W Shuler, H B Jones, et al.
Neurogenetics|February 7, 2001
Evidence that allelic variants of the spinocerebellar ataxia type 2 gene influence susceptibility to multiple sclerosisJ Chataway, S Sawcer, F Coraddu, et al.
Journal of Neuroimmunology|August 3, 1999
A screen of candidates from peaks of linkage: evidence for the involvement of myeloperoxidase in multiple sclerosisJ Chataway, S Sawcer, R Feakes, et al.
Nature Genetics|August 1, 1996
A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22S Sawcer, H B Jones, R Feakes, et al.
Genetic Epidemiology|May 14, 1999
Exploring the dense mapping of a region of potential linkage in complex disease: an example in multiple sclerosisR Feakes, S Sawcer, J Chataway, et al.
British Journal of Pharmacology|June 18, 1999
Anti-inflammatory activity of c(ILDV-NH(CH2)5CO), a novel, selective, cyclic peptide inhibitor of VLA-4-mediated cell adhesionD Haworth, A Rees, P J Alcock, et al.
Toxicology and Applied Pharmacology|September 30, 1987
The mechanism of acute cytotoxicity of triethylphosphine gold(I) complexes. I. Characterization of triethylphosphine gold chloride-induced biochemical and morphological changes in isolated hepatocytesG F Rush, P F Smith, D W Alberts, et al.
Neurogenetics|May 18, 1999
HLA typing in the United Kingdom multiple sclerosis genome screenF Coraddu, S Sawcer, R Feakes, et al.
Journal of Neuroimmunology|September 25, 1999
No evidence for association of multiple sclerosis with the complement factors C6 and C7J Chataway, S Sawcer, D Sherman, et al.
Pageof 12

Showing results (101-110 of 111) with videos related to

Sort By:
Pageof 12
Diabetes, Obesity & Metabolism|October 1, 2010
The novel sodium glucose transporter 2 inhibitor dapagliflozin sustains pancreatic function and preserves islet morphology in obese, diabetic ratsF R Macdonald, J E Peel, H B Jones, et al.
Surgical Endoscopy|February 15, 2001
Laparoscopic inguinal hernia repair: lessons learned after 1224 consecutive casesB Ramshaw, F W Shuler, H B Jones, et al.
Neurogenetics|February 7, 2001
Evidence that allelic variants of the spinocerebellar ataxia type 2 gene influence susceptibility to multiple sclerosisJ Chataway, S Sawcer, F Coraddu, et al.
Journal of Neuroimmunology|August 3, 1999
A screen of candidates from peaks of linkage: evidence for the involvement of myeloperoxidase in multiple sclerosisJ Chataway, S Sawcer, R Feakes, et al.
Nature Genetics|August 1, 1996
A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22S Sawcer, H B Jones, R Feakes, et al.
Genetic Epidemiology|May 14, 1999
Exploring the dense mapping of a region of potential linkage in complex disease: an example in multiple sclerosisR Feakes, S Sawcer, J Chataway, et al.
British Journal of Pharmacology|June 18, 1999
Anti-inflammatory activity of c(ILDV-NH(CH2)5CO), a novel, selective, cyclic peptide inhibitor of VLA-4-mediated cell adhesionD Haworth, A Rees, P J Alcock, et al.
Toxicology and Applied Pharmacology|September 30, 1987
The mechanism of acute cytotoxicity of triethylphosphine gold(I) complexes. I. Characterization of triethylphosphine gold chloride-induced biochemical and morphological changes in isolated hepatocytesG F Rush, P F Smith, D W Alberts, et al.
Neurogenetics|May 18, 1999
HLA typing in the United Kingdom multiple sclerosis genome screenF Coraddu, S Sawcer, R Feakes, et al.
Journal of Neuroimmunology|September 25, 1999
No evidence for association of multiple sclerosis with the complement factors C6 and C7J Chataway, S Sawcer, D Sherman, et al.
Pageof 12